BridgeMD
New treatment option for Diabetes Type 2
Official title Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial
ClinicalTrials.gov ID: NCT07485075
What this study is testing
- What it's testing
- This study evaluates whether a digital patient education program can improve adherence to KDIGO 2022 dietary recommendations (low sodium and optimal protein intake) among patients with type 2 diabetes and chronic kidney disease (eGFR 30-59 ml/min).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 74
You may be able to join if
- Type 2 diabetes (ICD-10 DE11.x)
- Age 18-74 years
- BMI \< 35 kg/m²
- eGFR 30-59 ml/min and UACR \> 30 mg/g
- Stable medication for ≥3 months
You likely can't join if
- Type 1 diabetes or other diabetes types
- Current vegan diet
- Active cancer
- Short bowel syndrome or celiac disease
- Use of sodium chloride tablets
- No access to digital platform (intervention group only)
See the full eligibility criteria
- Type 2 diabetes (ICD-10 DE11.x)
- Age 18-74 years
- BMI \< 35 kg/m²
- eGFR 30-59 ml/min and UACR \> 30 mg/g
- Stable medication for ≥3 months
- Ability to read and understand Danish
- Type 1 diabetes or other diabetes types
- Current vegan diet
- Active cancer
- Short bowel syndrome or celiac disease
- Use of sodium chloride tablets
- No access to digital platform (intervention group only)
The study team makes the final eligibility decision.
Where it's taking place
- Herlev, Captial Region of Denmark, Denmark
- Hillerød, Captial Region of Denmark, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 74 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Herlev, Captial Region of Denmark, Denmark; Hillerød, Captial Region of Denmark, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.